Market Tracker

10/24 6:05pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

6.02
Data as of Oct 24
 +0.56 / +10.26%
Today’s Change
1.76
Today|||52-Week Range
8.44
+28.09%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close5.46
Today’s open5.46
Day’s range5.40 - 6.08
Volume1,347,489
Average volume (3 months)317,954
Market cap$258.7M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-157.14%
Earnings growth (this year)-29.52%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales79.29
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.03+1.08%
CNCEConcert Pharmaceutic...+0.02+0.15%
CCXIChemoCentryx Inc-0.23-3.87%
ADMSAdamas Pharmaceutica...+0.12+0.79%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$1.9M
Annual profit (last year)-$51.2M
Net profit margin-2,733.92%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles Daniel Myers
Secretary, Chief Operating &
Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts